It's a run-of-the-mill 97% gain for shares of Transcept Pharmaceuticals (TSPT) following...

|By:, SA News Editor

It's a run-of-the-mill 97% gain for shares of Transcept Pharmaceuticals (TSPT) following yesterday's announcement the FDA was "generally" on board with its Intermezzo drug. Even with the blockbuster day, shares of the micro-cap are still off 11% for the year.